# Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas

> **NCT00788099** · PHASE1 · COMPLETED · sponsor: **PharmaMar** · enrollment: 45 (actual)

## Conditions studied

- Advanced Solid Tumors
- Lymphomas

## Interventions

- **DRUG:** Plitidepsin and Sorafenib
- **DRUG:** Gemcitabine and Plitidepsin

## Key facts

- **NCT ID:** NCT00788099
- **Lead sponsor:** PharmaMar
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2011-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788099, "Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00788099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*